Pharmaceuticals in Russia
Pharmaceuticals in Russia
SUMMARY
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Russian pharmaceuticals market had total revenues of $28,423.6m in 2019, representing a compound annual growth rate (CAGR) of 9.9% between 2015 and 2019.
- The Russian market has been driven by both an increase in unit sales and a shift towards more expensive drugs.
- Alcohol consumption is also higher in this region, which has led to cardiovascular diseases and cancer being prominent ailments, driving demand for treatments.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
- What was the size of the Russia pharmaceuticals market by value in 2019?
- What will be the size of the Russia pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Russia pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Russia's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. Are there any other notable players in the market?
7.5. What threats do leading players face?
7.6. What impact is COVID-19 having on the market?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. Bayer AG
8.3. Les Laboratoires Servier
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. Are there any other notable players in the market?
7.5. What threats do leading players face?
7.6. What impact is COVID-19 having on the market?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. Bayer AG
8.3. Les Laboratoires Servier
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Russia pharmaceuticals market value: $ billion, 2015-19
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Russia pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Russia pharmaceuticals market share: % share, by value, 2019
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: Bayer AG: key facts
Table 10: Bayer AG: Annual Financial Ratios
Table 11: Bayer AG: Key Employees
Table 12: Les Laboratoires Servier: key facts
Table 13: Les Laboratoires Servier: Key Employees
Table 14: Novartis AG: key facts
Table 15: Novartis AG: Annual Financial Ratios
Table 16: Novartis AG: Annual Financial Ratios (Continued)
Table 17: Novartis AG: Key Employees
Table 18: Novartis AG: Key Employees Continued
Table 19: Russia size of population (million), 2015-19
Table 20: Russia gdp (constant 2005 prices, $ billion), 2015-19
Table 21: Russia gdp (current prices, $ billion), 2015-19
Table 22: Russia inflation, 2015-19
Table 23: Russia consumer price index (absolute), 2015-19
Table 24: Russia exchange rate, 2015-19
Table 1: Russia pharmaceuticals market value: $ billion, 2015-19
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Russia pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Russia pharmaceuticals market share: % share, by value, 2019
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: Bayer AG: key facts
Table 10: Bayer AG: Annual Financial Ratios
Table 11: Bayer AG: Key Employees
Table 12: Les Laboratoires Servier: key facts
Table 13: Les Laboratoires Servier: Key Employees
Table 14: Novartis AG: key facts
Table 15: Novartis AG: Annual Financial Ratios
Table 16: Novartis AG: Annual Financial Ratios (Continued)
Table 17: Novartis AG: Key Employees
Table 18: Novartis AG: Key Employees Continued
Table 19: Russia size of population (million), 2015-19
Table 20: Russia gdp (constant 2005 prices, $ billion), 2015-19
Table 21: Russia gdp (current prices, $ billion), 2015-19
Table 22: Russia inflation, 2015-19
Table 23: Russia consumer price index (absolute), 2015-19
Table 24: Russia exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Russia pharmaceuticals market value: $ billion, 2015-19
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Russia pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Russia, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Russia, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Russia, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2019
Figure 10: Russia pharmaceuticals market share: % share, by value, 2019
Figure 1: Russia pharmaceuticals market value: $ billion, 2015-19
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Russia pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Russia, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Russia, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Russia, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2019
Figure 10: Russia pharmaceuticals market share: % share, by value, 2019
